4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000159
Director sold 15,000 shares at an average $23.24 ($348,665)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hughes Douglas J. Director | 2025-12-01 | Sale 10b5-1 | −13,091 | $23.14 | $302,926 | 122,682 | D |
| Hughes Douglas J. Director | 2025-12-01 | Sale 10b5-1 | −1,909 | $23.96 | $45,740 | 120,773 | D |
| Open-market sales · 15,000 sh · avg $23.24 · $348,665 | |||||||
Loading xslF345X05/wk-form4_1764803660.xml…